GLP-1 Market
LLY $1364.73 ▼ -3.8% NVO $40.30 ▼ -4.5% PFE $29.88 ▼ -3.0% VKTX $25.79 ▼ -7.8% KLRA $12.17 ▼ -4.9% GPCR $19.08 ▼ -6.3% RHHBY $59.45 ▼ -2.4%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Coagadex

Company
Kedrion S.p.A.
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
4 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

4 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Nov 6, 2026

Find a Clinical Trial Near Me

See recruiting studies for Coagadex and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT04023019

    Treatment of Hemophilia A Patients With FVIII Inhibitors

    Emory University 120 participants Est. completion 2029-06 2 sites
    Other conditions: Hemophilia A
    View official trial listing →
  • Recruiting NCT NCT04563520

    SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis

    Not yet reported Emory University 5 participants Est. completion 2027-03 2 sites
    Other conditions: Hemophilia A
    View official trial listing →
  • Recruiting NCT NCT04567511

    Hemlibra in Mild Hemophilia A

    Not yet reported Indiana Hemophilia &Thrombosis Center, Inc. 20 participants Est. completion 2027-07 1 site
    Other conditions: Factor VIII Deficiency, Congenital
    View official trial listing →
  • Recruiting NCT NCT07875478

    A Database For The Collection Of Clinical, Laboratory, And Treatment Data From Patients With Factor X Deficiency To Define The Natural History Of The Disease And Improve Patient Management

    Fondazione Luigi Villa 20 participants Est. completion 2029-06-14 2 sites
    Other conditions: Factor X Deficiency
    View official trial listing →
  • Status unknown NCT NCT00257179

    The Serum Tissue Factor Level in Lung Cancer Patients as a Prognostic Factor

    National Taiwan University Hospital 200 participants 1 site
    Other conditions: Lung Cancer
    View official trial listing →
  • Status unknown NCT NCT00458666

    Coagulation Parameters During Pregnancy in Amniotic Fluid

    Rambam Health Care Campus 170 participants 1 site
    Other conditions: Pregnancy
    View official trial listing →
  • Completed NCT NCT00930176

    A Study Investigating Treatment Factor X in People With Factor X Deficiency

    Not yet reported Bio Products Laboratory 16 participants Est. completion 2013-11 14 sites
    Other conditions: Factor X Deficiency
    View official trial listing →
  • Completed NCT NCT00970619

    DUTCH CAVA-trial: CAtheter Versus Anticoagulation Alone for Acute Primary (Ilio)Femoral DVT.

    Not yet reported Maastricht University Medical Center 184 participants Est. completion 2018-11 16 sites
    Other conditions: Acute Thrombosis of Deep Veins of Proximal Lower Extremity
    View official trial listing →
  • Completed NCT NCT00986635

    Effect of Rivaroxaban on Coagulation Parameters- an ex Vivo Study

    Johann Wolfgang Goethe University Hospital 100 participants Est. completion 2011-04 1 site
    Other conditions: Differences in Laboratory Coagulation Parameters
    View official trial listing →
  • Terminated NCT NCT01086852

    Safety & Efficacy of BPL's High Purity FACTOR X in Treatment of Factor X Deficient Subjects Undergoing Surgery

    Not yet reported Bio Products Laboratory 4 participants Est. completion 2014-01 7 sites
    Other conditions: Factor X Deficiency
    View official trial listing →
  • Completed NCT NCT01352143

    Thrombin Generation in Neonatal Plasma After Cardiopulmonary Bypass

    Emory University 24 participants Est. completion 2012-06 1 site
    Other conditions: Cardiopulmonary Bypass
    View official trial listing →
  • Completed NCT NCT01656330

    A Study to Assess the Effects of 2 Different Prothrombin Complex Concentrates on the Pharmacodynamics of Rivaroxaban in Healthy Adult Volunteers

    Not yet reported Janssen Research & Development, LLC 35 participants Est. completion 2012-08 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01660061

    Monitoring Anticoagulant Therapy in Antiphospholipid Syndrome

    Johann Wolfgang Goethe University Hospital 150 participants Est. completion 2014-12 1 site
    Other conditions: Antiphospholipid Syndrome
    View official trial listing →
  • Completed NCT NCT01687491

    Comparison of Anti-Xa Activity of ENOXA ® Versus LOVENOX ® in Acute Coronary Syndrome

    Not yet reported Les Laboratoires des Médicaments Stériles 179 participants Est. completion 2014-10 1 site
    Other conditions: Acute Coronary Syndrome, Factor X
    View official trial listing →
  • Completed NCT NCT01721681

    A Study to Investigate Bio Product Laboratory Ltd (BPL's) Factor X in the Prophylaxis of Bleeding in Children <12 Years

    Not yet reported Bio Products Laboratory 9 participants Est. completion 2016-10 3 sites
    Other conditions: Factor X Deficiency
    View official trial listing →
  • Completed NCT NCT02047565

    A Two-part Study in Edoxaban-treated Healthy Subjects to Establish a Punch Biopsy Bleeding Model and to Evaluate the Effect of a 4-factor Prothrombin Complex Concentrate on Anticoagulation

    Not yet reported Daiichi Sankyo 110 participants Est. completion 2014-05 1 site
    Other conditions: Bleeding
    View official trial listing →
  • Completed NCT NCT02074358

    A Study to Assess the Effects of 2 Prothrombin Complex Concentrates on the Pharmacodynamics of Apixaban in Healthy Adult Subjects

    Not yet reported Bristol-Myers Squibb 43 participants Est. completion 2014-04
    Other conditions: Anticoagulation
    View official trial listing →
  • Completed NCT NCT02099318

    Surgical Theater's Surgery Rehearsal Platform

    Not yet reported University Hospitals Cleveland Medical Center 40 participants Est. completion 2015-09 1 site
    Other conditions: Cerebral Aneurysm Unruptured, Cerebral Aneurysm Ruptured
    View official trial listing →
  • Completed NCT NCT02319460

    An Observational Cohort Study to Investigate the Risk of Thromboembolic Events in Patients Receiving Kcentra® or Plasma to Reverse Vitamin K Antagonist (VKA) Therapy in the Setting of Acute Major Bleeding

    CSL Behring 2238 participants Est. completion 2020-06-30 1 site
    Other conditions: Hemorrhage
    View official trial listing →
  • Status unknown NCT NCT02463591

    Reversal of Dabigatran With Prothrombin Complex Concentrate

    Not yet reported University Medical Center Groningen 12 participants Est. completion 2016-12 1 site
    Other conditions: Drug Action Reversal
    View official trial listing →
  • Completed NCT NCT02740335

    Study of Octaplex, a Four-factor Prothrombin Complex Concentrate (4F-PCC) and Beriplex® P/N (Kcentra) for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk.

    Not yet reported Octapharma 208 participants Est. completion 2022-02-23 86 sites
    Other conditions: Significant Bleeding Risk
    View official trial listing →
  • Completed NCT NCT02914353

    Study to Evaluate Safety, PK and PD of Single and Multiple Ascending Doses of EP-7041 in Healthy Subjects

    Not yet reported eXIthera Pharmaceuticals 80 participants Est. completion 2017-05 1 site
    Other conditions: Arthroplasty, Replacement, Knee
    View official trial listing →
  • Completed NCT NCT03161626

    Registry Study of COAGADEX® Patients With Moderate or Severe Hereditary Factor X Deficiency Undergoing Major Surgery

    Bio Products Laboratory 3 participants Est. completion 2021-10-13 3 sites
    Other conditions: Factor 10 Deficiency
    View official trial listing →
  • Completed NCT NCT03270865

    Usability and Ergonomic Evaluation of Self-Positioning System for Retinal Imaging

    Not yet reported Notal Vision Ltd. 16 participants Est. completion 2018-09-30 1 site
    Other conditions: AMD Population - Intermediate or Advanced AMD, DR Population- With or Without Diabetic Macular Edema
    View official trial listing →
  • Status unknown NCT NCT03287999

    Inter Individual Variability in Initiation Pathway Activation and Regulation and Phenotypic Heterogeneity in Patients With Haemophilia A and B

    Royal Free Hospital NHS Foundation Trust 250 participants Est. completion 2020-10-02 1 site
    Other conditions: Haemophilia
    View official trial listing →
  • Status unknown NCT NCT03347591

    Rare Bleeding Disorders in the Netherlands

    Radboud University Medical Center 300 participants Est. completion 2022-01-01 7 sites
    Other conditions: Rare Bleeding Disorders
    View official trial listing →
  • Terminated NCT NCT03921294

    HemLibra Prophylaxis in Patients With Hemophilic Pseudotumor

    Not yet reported Indiana Hemophilia &Thrombosis Center, Inc. 1 participants Est. completion 2022-03-16 1 site
    Other conditions: Haemophilic Pseudotumour
    View official trial listing →
  • Terminated NCT NCT04233073

    Trial of Andexanet in Patients Receiving an Oral FXa Inhibitor Who Require Urgent Surgery

    Not yet reported Alexion Pharmaceuticals, Inc. 10 participants Est. completion 2022-01-25 56 sites
    Other conditions: Surgery
    View official trial listing →
  • Terminated NCT NCT04244981

    Efficacy of Prothrombin Complex Concentrate Reducing Perioperative Blood Loss in Cardiac Surgery

    Not yet reported SHI Jia 476 participants Est. completion 2025-04-09 2 sites
    Other conditions: Valvular Heart Surgery
    View official trial listing →
  • Completed NCT NCT04372173

    An Evaluation of Clotting Factor Activity Before and After Total Hip Arthroplasty

    Military Institute od Medicine National Research Institute 30 participants Est. completion 2020-01-31 1 site
    Other conditions: Arthroplasty, Replacement, Coagulation Factors
    View official trial listing →
  • Status unknown NCT NCT04539301

    Multicentric Prospective Validation of a Universal Test to Quantify Apixaban, Rivaroxaban, Danaparoid and Fondaparinux Levels

    Nantes University Hospital 2100 participants Est. completion 2024-05-01 1 site
    Other conditions: Anticoagulation, Venous Thromboembolism, Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT04569279

    Rivaroxaban vs. Warfarin in CVT Treatment

    Not yet reported Damascus University 71 participants Est. completion 2020-03-01 1 site
    Other conditions: Cerebral Vein Thrombosis
    View official trial listing →
  • Completed NCT NCT05012501

    Analysis of Neutrophil Extracellular Traps in Hypercoagulability and Portal Vein Thrombosis in Liver Cirrhosis Patients

    The Affiliated Hospital of Qingdao University 79 participants Est. completion 2021-02-28 1 site
    Other conditions: Neutrophil Extracellular Trap Formation, Portal Vein Thrombosis, Liver Cirrhosis
    View official trial listing →
  • Completed NCT NCT05152420

    Study of Intravenous VMX-C001 in Healthy Subjects and in Combination With Selected Direct Oral Anticoagulants in Healthy Older Subjects

    Not yet reported VarmX B.V. 105 participants Est. completion 2023-02-03 1 site
    Other conditions: Coagulation Disorder
    View official trial listing →
  • Completed NCT NCT05226442

    Safety and Feasibility of Argatroban As Anticoagulant in Adults with ECMO

    Not yet reported, Not yet reported Medical University of Vienna 40 participants Est. completion 2024-07-07 1 site
    Other conditions: Extracorporeal Membrane Oxygenation Complication, Anticoagulants and Bleeding Disorders
    View official trial listing →
  • Terminated NCT NCT05568888

    Evaluation of BE1116 in Patients With Traumatic Injury and Acute Major Bleeding to Improve Survival ( TAP Study )

    Not yet reported CSL Behring 1366 participants Est. completion 2024-10-29 113 sites
    Other conditions: Traumatic Injury
    View official trial listing →
  • Completed NCT NCT06372483

    Single Dose Trial of VMX-C001 in Healthy Subjects With and Without FXa Direct Oral Anticoagulant

    Not yet reported VarmX B.V. 40 participants Est. completion 2026-08-26 1 site
    Other conditions: Coagulation Disorder
    View official trial listing →
  • Completed NCT NCT06517563

    Effects of VMX-C001 on the Anticoagulant Effect of Different Forms of Heparin

    Not yet reported VarmX B.V. 16 participants Est. completion 2026-04-13 1 site
    Other conditions: Coagulation Disorder
    View official trial listing →
  • Terminated NCT NCT06929260

    A Study to Evaluate the Effect of Ceralasertib on Drug X, Drug Y and Drug Z

    Not yet reported AstraZeneca 1 participants Est. completion 2025-12-18 1 site
    Other conditions: Advanced Solid Tumours
    View official trial listing →
  • Withdrawn NCT NCT06963216

    A Study Investigating Coagadex in the Treatment AFXD Associated With AL Amyloidosis

    Not yet reported Kedrion S.p.A. Est. completion 2026-06-10 Stand-alone
    Other conditions: Acquired Factor X Deficiency
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Coagadex, Coagadex(R)

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.